Electronic Standards Key To Better Demographic Data In Trials – McClellan
This article was originally published in The Gray Sheet
Executive Summary
Electronic clinical trial databases under development at the FDA Office of Women's Health will help sponsors design trials that account for gender and other demographic differences among patients, according to Commissioner Mark McClellan
You may also be interested in...
Generalizability Of Prophylactic ICD Benefits Questioned By CMS, Panelists
CMS' reliance on the precise wording of Guidant's original national coverage determination request for expanded ICD use suggests the need for companies to tailor their requests to avoid overly broad interpretations
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.